I-Mab Biopharma, a biotech company focusing exclusively on innovative biologics in immuno-oncology and auto-immune diseases, and WuXi Biologics have entered into a long term strategic partnership on biologics process development, clinical and commercial manufacturing of I-Mab’s pipelines.   Under the terms of the partnership, I-Mab will leverage WuXi Bio’s know-how for CMC development of at least five programs and commercial manufacturing of at least one program for its proprietary m...